On-Line & At-Line Antibody Quantification

About ArgusEye

ArgusEye is a private, commercial-stage diagnostics and digital health company providing a hardware and consumables platform for real-time bioprocess analytics. Its patented Auga™ platform, centered on LSPR biosensor technology, offers continuous monitoring of targets like antibodies and aggregates directly in the process stream, aligning with Process Analytical Technology (PAT) initiatives. The company's solutions are designed to reduce development time and costs for biologics manufacturers, a value proposition recently bolstered by a significant €6.25 million grant from the European Innovation Council (EIC) Accelerator. ArgusEye operates in the high-growth bioprocess analytical instrumentation market, competing on the specificity and real-time capability of its label-free sensing technology.